𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Moclobemide pharmacokinetics in depressed patients: Lack of age effect

✍ Scribed by K. Maguire; A. Pereira; J. Tiller

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
364 KB
Volume
6
Category
Article
ISSN
0885-6222

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The pharmacokinetics of moclobemide were examined in 19 depressed patients following a single oral dose of 50 mg. Ten patients were aged >60 years and nine <59 years. Plasma concentrations were analysed by gas chromatography with nitrogen‐specific detection. Pharmacokinetic parameters calculated were peak concentration, time to reach the peak, terminal disposition half‐life, area under the curve, oral clearance and apparent volume of distribution. No clinically significant differences were found betwen the two patient groups for these parameters. Thus there is no requirement for dosage adjustment in the older patient for moclobemide. This contrasts with some tricyclic and tetracyclic antidepressants which show significant age effects. Further studies of moclobemide for the treatment of elderly depression are warranted.

πŸ“œ SIMILAR VOLUMES

Moclobemide treatment of resistant depre
Moclobemide treatment of resistant depression in a patient with vascular dementia
✍ Yoram Barak; Hanna Suholitsky; Shlomo Noy πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 198 KB πŸ‘ 2 views

Patients suffering from dementia exhibit depressive symptoms in up to 86 per cent of cases. Syndromes meeting the criteria for major depression are more likely to respond to pharmacological therapy. Increased activity of M A 0 found in demented subjects make the treatment with MAO-inhibitors an obvi

A sequential double-blind controlled stu
A sequential double-blind controlled study of moclobemide and mianserin in elderly depressed patients
✍ John Tiller; Dr Kay Maguire; Brian Davies πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 498 KB πŸ‘ 2 views

Moclobemide was compared with mianserin in a double-blind controlled study in elderly depressed patients. Sequential analysis of 1 1 pairs of patients found no significant difference between the drugs at the week 8 analysis. Unpaired comparison of the 26 patients completing four weeks' treatment als